Ignite Creation Date:
2024-05-06 @ 1:29 AM
Last Modification Date:
2024-10-26 @ 11:04 AM
Study NCT ID:
NCT01818232
Status:
COMPLETED
Last Update Posted:
2013-06-18
First Post:
2013-03-21
Brief Title:
Study to Determine the Absorption Metabolism and Excretion of 14CLX4211 in Healthy Male Subjects
Sponsor:
Lexicon Pharmaceuticals
Organization:
Lexicon Pharmaceuticals
Study Overview
Official Title:
A Phase 1 Open-label Nonrandomized Single Dose Study to Evaluate the Absorption Metabolism and Excretion of 14C-LX4211 Following Oral Administration in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AME
Brief Summary:
This phase 1 study is to evaluate the pharmacokinetics PK metabolism routes and extent of elimination of a single oral dose of 400 mg 14CLX4211 to healthy male subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| LX4211108 | None | None | None |